Parsa et al. [32, 33] measured the expression of PD-L1 in glioma cells and found that glioma cells with genetic deletions or mutations of the phosphatase and tensin homolog (PTEN) genes exhibit greater PD-L1 protein levels than cells with wild-type PTEN. The gene discussed is PTEN; the disease is central nervous system cancer.